Moreover, the suppression of SLC7A11 weakened the proliferation and viability in H358 cells, further supporting the suggestion that high SLC7A11 levels are indicative of a poor prognosis in NSCLC patients [21]. Here, SLC7A11 is linked to non-small cell lung carcinoma.